EGCG has also been found to inhibit cyclo-oxygenase 2 (COX-2) enzyme activity, primarily through suppression of the MAPK pathway, which is linked to its effects on the cell cycle and cancer cell death [127,139]. Here, PTGS2 is linked to cancer.